Maxcyte (MXCT) Interest Expenses (2020 - 2026)

Maxcyte (MXCT) has 7 years of Interest Expenses data on file, last reported at $2.4 million in Q1 2026.

• On a quarterly basis, Interest Expenses fell 91.03% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 91.03% decrease from a year earlier, with the FY2025 full-year figure at $66.5 million, up 21.27% from the prior year.
• Interest Expenses for Q1 2026 stood at $2.4 million, down from $66.5 million in the prior quarter.
• Over the last five years, Interest Expenses for MXCT reached as high as $66.5 million in Q4 2025 and fell as low as $1.8 million in Q2 2022.
• Historically, Interest Expenses has averaged $18.8 million across 5 years, with a median of $15.9 million in 2023.
• Across the five-year window, Interest Expenses soared 471324.07% in 2022 and sank 92.84% in 2023, its largest moves.
• Year by year, Interest Expenses stood at $23.8 million in 2022, then plunged by 33.46% to $15.9 million in 2023, then jumped by 246.09% to $54.9 million in 2024, then rose by 21.27% to $66.5 million in 2025, then plunged by 96.4% to $2.4 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $2.4 million in Q1 2026, $66.5 million in Q4 2025, and $7.2 million in Q3 2025.